US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lunai Bioworks

0.4936

+0.092122.94%

Post-market: 0.4580-0.0356-7.21%19:59 EDT

Volume:257.64M

Turnover:178.22M

Market Cap:11.94M

PE:-0.07

High:0.9480

Open:0.9205

Low:0.4828

Close:0.4015

52wk High:7.29

52wk Low:0.1513

Shares:24.19M

Float Shares:14.71M

Volume Ratio:13.44

T/O Rate:1751.93%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.5469

EPS(LYR):-10.7843

ROE:-366.44%

ROA:-13.32%

PB:-0.88

PE(LYR):-0.05

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Lunai Bioworks acquires Clemann Group BBB delivery technology and CNS Alzheimer’s assets; deal totals $20 million at $1.50 conversion price

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring Bbb Delivery Platform for CNS Alzheimer's Therapies With Broad CNS Delivery Applications

THOMSON REUTERS

Lunai Bioworks announces formation of Pathfinder Consortium

Lunai Bioworks launches Pathfinder Consortium to develop chemical countermeasures in 36 months

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LNAI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LNAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","market":"US","secType":"STK","nameCN":"Lunai Bioworks","latestPrice":0.4936,"timestamp":1774555200000,"preClose":0.4015,"halted":0,"volume":257635578,"hourTrading":{"tag":"盘后","latestPrice":0.458,"preClose":0.4936,"latestTime":"19:59 EDT","volume":4216085,"amount":2182183.040461,"timestamp":1774569599510,"change":-0.0356,"changeRate":-0.072123,"amplitude":0.251216},"delay":0,"changeRate":0.22938978829389778,"floatShares":14705800,"shares":24187399,"eps":-7.5469,"marketStatus":"Not Yet Opened","change":0.0921,"latestTime":"03-26 16:00:00 EDT","open":0.9205,"high":0.948,"low":0.4828,"amount":178216046.36085132,"amplitude":1.158655,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.5469,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774598400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4015,"preHourTrading":{"tag":"盘前","latestPrice":0.9165,"preClose":0.4015,"latestTime":"09:29 EDT","volume":33188942,"amount":29484535.0064106,"timestamp":1774531799795,"change":0.515,"changeRate":1.28269,"amplitude":1.693649},"postHourTrading":{"tag":"盘后","latestPrice":0.458,"preClose":0.4936,"latestTime":"19:59 EDT","volume":4216085,"amount":2182183.040461,"timestamp":1774569599510,"change":-0.0356,"changeRate":-0.072123,"amplitude":0.251216},"volumeRatio":13.437088,"impliedVol":1.4337,"impliedVolPercentile":0.8},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","floatShares":14705800,"roa":"-13.32%","roe":"-366.44%","lyrEps":-10.784282,"volumeRatio":13.437088,"shares":24187399,"dividePrice":0,"high":0.948,"amplitude":1.158655,"preClose":0.4015,"low":0.4828,"week52Low":0.1513,"pbRate":"-0.88","week52High":7.29,"institutionHeld":0,"latestPrice":0.4936,"eps":-7.5469,"divideRate":0,"volume":257635578,"delay":0,"ttmEps":-7.5469,"open":0.9205,"prevYearClose":0.8817,"prevWeekClose":0.4685,"prevMonthClose":0.3705,"prevQuarterClose":0.8817,"fiveDayClose":0.385,"twentyDayClose":0.4,"sixtyDayClose":0.9305},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LNAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-17","symbol":"LNAI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1771304400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-11-14","symbol":"LNAI","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-09-30","symbol":"LNAI","defaultRemindTime":1759239000000,"type":"split","dateTimestamp":1759204800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-09-29","symbol":"LNAI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"","actualEps":-0.76},{"market":"US","date":"2025-05-15","symbol":"LNAI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":0}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LNAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LNAI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LNAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LNAI","date":"2026-03-25","current":-0.065404,"percent":0.932773,"low":-0.265446,"twenty":-0.176842,"median":-0.1517,"eighty":-0.110696,"high":-0.035532,"avg":-0.145661,"sd":0.049974,"marketCap":8828384},"quantilePoints":[{"date":"2025-10-03","current":-0.160171,"twenty":-0.164877,"median":-0.163112,"eighty":-0.161348,"marketCap":28511703},{"date":"2025-10-10","current":-0.161474,"twenty":-0.165919,"median":-0.164078,"eighty":-0.161474,"marketCap":28743506},{"date":"2025-10-17","current":-0.158869,"twenty":-0.16512,"median":-0.161474,"eighty":-0.158869,"marketCap":28279901},{"date":"2025-10-24","current":-0.135429,"twenty":-0.16512,"median":-0.160171,"eighty":-0.152098,"marketCap":24107456},{"date":"2025-10-31","current":-0.122514,"twenty":-0.163557,"median":-0.158218,"eighty":-0.135687,"marketCap":21808324},{"date":"2025-11-07","current":-0.132813,"twenty":-0.161474,"median":-0.152344,"eighty":-0.130739,"marketCap":23641716},{"date":"2025-11-14","current":-0.134115,"twenty":-0.161474,"median":-0.143888,"eighty":-0.121701,"marketCap":23873497},{"date":"2025-11-21","current":-0.254829,"twenty":-0.163557,"median":-0.147149,"eighty":-0.123011,"marketCap":33376540},{"date":"2025-11-28","current":-0.211108,"twenty":-0.166054,"median":-0.152344,"eighty":-0.125001,"marketCap":27650221},{"date":"2025-12-05","current":-0.232577,"twenty":-0.211108,"median":-0.158218,"eighty":-0.130221,"marketCap":30462108},{"date":"2025-12-12","current":-0.20753,"twenty":-0.221843,"median":-0.160171,"eighty":-0.132813,"marketCap":27181573},{"date":"2025-12-19","current":-0.184259,"twenty":-0.212897,"median":-0.161474,"eighty":-0.134115,"marketCap":24133572},{"date":"2025-12-26","current":-0.176388,"twenty":-0.211466,"median":-0.164729,"eighty":-0.134115,"marketCap":23102623},{"date":"2026-01-02","current":-0.157729,"twenty":-0.211108,"median":-0.164729,"eighty":-0.134896,"marketCap":20658806},{"date":"2026-01-09","current":-0.162828,"twenty":-0.208961,"median":-0.16538,"eighty":-0.135424,"marketCap":21326580},{"date":"2026-01-16","current":-0.16442,"twenty":-0.206179,"median":-0.165717,"eighty":-0.136203,"marketCap":21535113},{"date":"2026-01-23","current":-0.164223,"twenty":-0.200455,"median":-0.16538,"eighty":-0.13724,"marketCap":21509339},{"date":"2026-01-30","current":-0.150287,"twenty":-0.192502,"median":-0.16442,"eighty":-0.139063,"marketCap":19684091},{"date":"2026-02-06","current":-0.115725,"twenty":-0.190708,"median":-0.163453,"eighty":-0.135462,"marketCap":15157289},{"date":"2026-02-13","current":-0.146316,"twenty":-0.189626,"median":-0.161474,"eighty":-0.135462,"marketCap":19163931},{"date":"2026-02-20","current":-0.111222,"twenty":-0.189268,"median":-0.161474,"eighty":-0.134115,"marketCap":13960941},{"date":"2026-02-27","current":-0.077077,"twenty":-0.187121,"median":-0.158869,"eighty":-0.128849,"marketCap":9674942},{"date":"2026-03-06","current":-0.069658,"twenty":-0.184259,"median":-0.157729,"eighty":-0.122516,"marketCap":8743729},{"date":"2026-03-13","current":-0.037035,"twenty":-0.183139,"median":-0.156666,"eighty":-0.116398,"marketCap":4648809},{"date":"2026-03-20","current":-0.074186,"twenty":-0.178206,"median":-0.153221,"eighty":-0.113305,"marketCap":9312132},{"date":"2026-03-25","current":-0.070333,"twenty":-0.176842,"median":-0.1517,"eighty":-0.110696,"marketCap":8828384}],"updateTime":1774563114852},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LNAI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622478850","title":"Lunai Bioworks acquires Clemann Group BBB delivery technology and CNS Alzheimer’s assets; deal totals $20 million at $1.50 conversion price","url":"https://stock-news.laohu8.com/highlight/detail?id=2622478850","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622478850?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:51","pubTimestamp":1774529482,"startTime":"0","endTime":"0","summary":"Lunai Bioworks acquires Clemann Group BBB delivery technology and CNS Alzheimer’s assets; deal totals $20 million at $1.50 conversion price. Lunai Bioworks entered a binding strategic transaction valued at USD 20 million to acquire blood-brain barrier delivery technology and CNS Alzheimer’s drug assets from the Clemann Group.The consideration is structured as Series B convertible preferred stock with a fixed conversion price of USD 1.50 per share.The conversion is subject to a 19.9% beneficial ownership limitation.The acquired platform is intended to support delivery of therapeutics into the brain for Alzheimer’s and other CNS indications.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3fXRpj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"gpt_icon":0},{"id":"2622410850","title":"Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring Bbb Delivery Platform for CNS Alzheimer's Therapies With Broad CNS Delivery Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2622410850","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622410850?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:51","pubTimestamp":1774529474,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LNAI","BK4139"],"gpt_icon":0},{"id":"2620133229","title":"Lunai Bioworks announces formation of Pathfinder Consortium","url":"https://stock-news.laohu8.com/highlight/detail?id=2620133229","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620133229?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:10","pubTimestamp":1773929431,"startTime":"0","endTime":"0","summary":"Lunai Bioworks (LNAI) announced the formation of a national consortium designed to accelerate the discovery and development of chemical countermeas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-announces-formation-of-pathfinder-consortium-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-announces-formation-of-pathfinder-consortium-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","PBHC","LNAI","BK4139"],"gpt_icon":0},{"id":"2620226176","title":"Lunai Bioworks launches Pathfinder Consortium to develop chemical countermeasures in 36 months","url":"https://stock-news.laohu8.com/highlight/detail?id=2620226176","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620226176?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:58","pubTimestamp":1773928715,"startTime":"0","endTime":"0","summary":"Lunai Bioworks said its BioSymetrics unit formed the Pathfinder Consortium to coordinate academic, military, and biotech efforts on chemical countermeasure discovery and development.The company described a development model aiming to complete efficacy and safety steps in about 36 months, including a 50-person Phase I safety study.The program includes screening in yeast and cell-based systems, followed by validation in FDA-recognized zebrafish models.Lunai said validated countermeasures are typically procured for U.S. government stockpiling programs ranging from USD 400 million to USD 1.2 billion per program.Named collaborators include Calum MacRae, Vik Bebarta, Randall Peterson, and Vincent Jo Davidson.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL3y24gL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LNAI\",params:#limit:6,delay:false,,,undefined,":[]}}